J F Smyth1, S Gundersen, J Renard, H M Pinedo. Show Affiliations » 1. Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland, U.K.
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAgedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useDrug EvaluationFemaleHumansMaleMelanoma/drug therapyMiddle AgedNitrogen Mustard Compounds/adverse effectsNitrogen Mustard Compounds/therapeutic useNitrosourea Compounds/adverse effectsNitrosourea Compounds/therapeutic useRandom AllocationTaurine/adverse effectsTaurine/analogs & derivativesTaurine/therapeutic use
Substances： See more » Antineoplastic AgentsNitrogen Mustard CompoundsNitrosourea CompoundsTaurine1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosoureamitozolomide
Year: 1989 PMID： 2714350 DOI： 10.1016/0277-5379(89)90216-2
Source DB: PubMed Journal: Eur J Cancer Clin Oncol ISSN： 0277-5379